Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 619 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

MethylGene names Charles Baum as new CEO

Previously, Baum served at Pfizer as senior vice president for clinical research, and vice president and head of oncology, where he developed oncology drugs including tyrosine kinase inhibitors

Sophiris Bio Q3 net loss widens

Expenses for third quarter of 2012 were $5.39m compared to $2.64m for the third quarter of 2011. The company reported a net loss of $15.84m, or $0.10 per